Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones. Patel SS, Wacholtz MC, Duby AD, Thiele DL, Lipsky PE. J Immunol. 1989 Aug 15;143(4):1108-17. PMID: 2526180
[Processing and T cell recognition of viral antigens]. Hosaka Y. Tanpakushitsu Kakusan Koso. 1992 Oct;37(14):2865-74. PMID: 1438861
Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones. Mills KH. Immunology. 1988 Nov;65(3):365-71. PMID: 2463222
Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. Davis CB, Mitchell DJ, Wraith DC, Todd JA, Zamvil SS, McDevitt HO, Steinman L, Jones PP. J Immunol. 1989 Oct 01;143(7):2083-93. PMID: 2476496
A cell line and clones of lymphocytes from a healthy donor, with specificity to S-antigen. Hirose S, McAllister CG, Mittal KK, Vistica BP, Shinohara T, Gery I. Invest Ophthalmol Vis Sci. 1988 Nov;29(11):1636-41. PMID: 2460417
Antigen presentation by non-immune B-cell hybridoma clones: presentation of synthetic antigenic sites reveals clones that exhibit no specificity and clones that present only one epitope. Cohly HH, Morrison DR, Atassi MZ. Immunol Invest. 1989 Oct;18(8):987-92. doi: 10.3109/08820138909045785. PMID: 2479600
Recognition by a human alloreactive T-cell clone of an HLA-DP-associated epitope on monocytes and fibroblasts but not on B cells. Umetsu DT, Jabara HH, Hauschka P, Geha RS. J Clin Immunol. 1988 May;8(3):163-70. doi: 10.1007/BF00917562. PMID: 2455729
The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Ramaswami B, Popescu I, Macedo C, Luo C, Shapiro R, Metes D, Chalasani G, Randhawa PS. Clin Vaccine Immunol. 2011 May;18(5):815-24. doi: 10.1128/CVI.00487-10. Epub 2011 Mar 02. PMID: 21367979
Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression. Steerenberg PA, De Jong WH, Geerse E, De Graaf A, Scheper RJ, Den Otter W, Ruitenberg EJ. Cancer Immunol Immunother. 1991;33(3):189-97. doi: 10.1007/BF01756141. PMID: 1828389
Class II MHC self-antigen presentation in human B and T lymphocytes. Costantino CM, Spooner E, Ploegh HL, Hafler DA. PLoS One. 2012;7(1):e29805. doi: 10.1371/journal.pone.0029805. Epub 2012 Jan 27. PMID: 22299025
Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis. Glisic S, Jailwala P. PLoS One. 2012;7(4):e36040. doi: 10.1371/journal.pone.0036040. Epub 2012 Apr 26. PMID: 22563437
A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function. Jacobs ES, Persad D, Ran L, Danesh A, Heitman JW, Deng X, Cameron MJ, Kelvin DJ, Norris PJ. Retrovirology. 2014 Jul 05;11:57. doi: 10.1186/1742-4690-11-57. PMID: 24996903
Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells. Costantino CM, Ploegh HL, Hafler DA. J Immunol. 2009 Jul 15;183(2):945-52. doi: 10.4049/jimmunol.0900921. Epub 2009 Jun 24. PMID: 19553543
Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin. Steerenberg PA, De Jong WH, Geerse E, Aleva BJ, Besselink CM, Van Rens BT, Rutten VP, Poels LG, Scheper RJ, Den Otter W. Cancer Immunol Immunother. 1990;32(2):95-104. doi: 10.1007/BF01754205. PMID: 1963114